Skip to main content
OpenTrials

Clinical trial condition

HER2-negative Breast Cancer

Explore clinical trials studying HER2-negative Breast Cancer. Study availability and eligibility vary by location and protocol.

109 public trials 55 recruiting studies
Refine in advanced search Browse all conditions

HER2-negative Breast Cancer trial results

Recruiting

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

NCT04585750

Conditions
Adnexal Diseases, Advanced Malignant Neoplasm, Advanced Solid Tumor, +81 more
Locations
  • University of California Irvine Chao Family Comprehensive Cancer Center Irvine, California, United States
  • University of San Diego Moores Cancer Center La Jolla, California, United States
  • UCLA Jonsson Comprehensive Cancer Center Los Angeles, California, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
View all 77 locations
View Trial Details
Recruiting

Elacestrant for Treating ER+/HER2- Breast Cancer Patients With ctDNA Relapse (TREAT ctDNA)

NCT05512364

Conditions
Breast Diseases, Breast Neoplasms, ER-positive Breast Cancer, +7 more
Locations
  • Institut Jules Bordet Anderlecht, Belgium
  • Cliniques Universitaires Saint-Luc Brussels, Belgium
  • Hopital Universitaire Brugmann Brussels, Belgium
  • Grand Hopital de Charleroi - Site Notre Dame Charleroi, Belgium
View all 112 locations
View Trial Details
Recruiting

BGB-21447 (Bcl-2 Inhibitor) Combinations for Adults With Hormone-Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Metastatic Breast Cancer

NCT06756932

Conditions
Breast Diseases, Breast Neoplasms, HER2-negative Breast Cancer, +6 more
Locations
  • University of Iowa Hospitals and Clinics Iowa City, Iowa, United States
  • Md Anderson Cancer Center Houston, Texas, United States
  • Fred Hutchinson Cancer Research Center Seattle, Washington, United States
  • Saint Vincents Hospital Sydney Darlinghurst, New South Wales, Australia
View all 14 locations
View Trial Details
Recruiting

BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors

NCT06120283

Conditions
Advanced Breast Cancer, Advanced Solid Tumor, Breast Diseases, +11 more
Locations
  • Sarah Cannon Research Institute (Scri) At Health One Denver, Colorado, United States
  • Florida Cancer Specialists and Research Institute Lake Mary, Florida, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • Washington University School of Medicine St Louis, Missouri, United States
View all 62 locations
View Trial Details
Recruiting

PRE-ISPY Phase I/II Oncology Platform Program

NCT05868226

Conditions
Adenocarcinoma, Adenocarcinoma of Colon, Breast Diseases, +51 more
Locations
  • The University of Alabama at Birmingham O'Neal Comprehensive Cancer Center Birmingham, Alabama, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • The University of Chicago Medicine Comprehensive Cancer Center Chicago, Illinois, United States
  • UChicago Medicine Comprehensive Cancer Center at Silver Cross Hospital New Lenox, Illinois, United States
View Trial Details
Recruiting

A Ph II Study of the TheraBionic P1 Device in Subjects With Hormone Positive Breast Cancer

NCT07227831

Conditions
Advanced Breast Cancer, Breast Diseases, Breast Neoplasms, +7 more
Locations
  • Karmanos Cancer Institute at McLaren Bay Region Bay City, Michigan, United States
  • Karmanos Cancer Institute at McLaren Clarkston Clarkston, Michigan, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • Karmanos Cancer Institute at McLaren Flint Flint, Michigan, United States
View Trial Details
Recruiting

TReatment of ADC-Refractory Breast CancEr With Dato-DXd or T-DXd: TRADE DXd

NCT06533826

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +7 more
Locations
  • University of Alabama Birmingham, Alabama, United States
  • University of San Francisco San Francisco, California, United States
  • Yale University Cancer Center New Haven, Connecticut, United States
  • Georgetown University Medical Center Washington D.C., District of Columbia, United States
View Trial Details

Related conditions